Clinical Trials Browser

Phase 2/3 × Breast Neoplasms × Ado-Trastuzumab Emtansine × Clear all

NCT05288777 2025-04-18

Breast53

Phase 2/3 Recruiting

Breast Neoplasms

NCT02568839 2020-08-13

PREDIX HER2

Phase 2/3 Active not recruiting

Breast Neoplasms